Thursday, April 23, 2020

Very low-dose Avastin effective for preventing blindness in preterm infants

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200423130503.htm

No comments:

Post a Comment